Conroy Kevin T
- SEC CIK
- 0001306119
No open-market purchases or sales filed in the past year.
Current role at each company
- ABT Abbott LaboratoriesDirectoras of Sep 25, 2026
- ALGN Align Technology IncDirectoras of May 22, 2026
- EXAS Exact Sciences CorpPresident and CEOas of Mar 23, 2026
- ADPT Adaptive Biotechnologies CorpDirectoras of Mar 8, 2023
- EPZM Epizyme, Inc.Directoras of Aug 16, 2022
Show 1 more company
- SLGC SomaLogic, Inc.Directoras of Sep 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Conroy Kevin T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXAS Exact Sciences Corp
President and CEO21 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 (view filing) | Nov 13 | Same day | Conroy Kevin TPresident and CEO | PPurchase | +19.5K | $51.35 | +$1.00M | +1.8%1.07M after | |
| May 2, 2024 (view filing) | May 1 | 1 day | Conroy Kevin TPresident and CEO | SSale | −1.16K | $60.15 | −$69.5K | −0.1%1.16M after | 10b5-1 |
| Mar 4, 2024 (view filing) | Mar 1 | 3 days | Conroy Kevin TPresident and CEO | SSale | −8.27K | $59.32 | −$490.6K | −0.6%1.30M after | 10b5-1 |
| Feb 28, 2024 (view filing) | Feb 27 | 1 day | Conroy Kevin TPresident and CEO | SSale | −6.26K | $56.89 | −$356.3K | −0.5%1.29M after | 10b5-1 |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Conroy Kevin TPresident and CEO | SSale | −11.6K | $59.78 | −$691.4K | −0.9%1.24M after | 10b5-1 |
| Feb 22, 2024 (view filing) | Feb 21 | 1 day | Conroy Kevin TPresident and CEO | SSale | −4.97K | $61.50 | −$306.0K | −0.4%1.23M after | 10b5-1 |
| Feb 16, 2024 (view filing) | Feb 15 | 1 day | Conroy Kevin TPresident and CEO | SSale | −14.8K | $61.43 | −$908.6K | −1.2%1.22M after | 10b5-1 |
| Mar 1, 2023 (view filing) | Feb 28 | 1 day | Conroy Kevin TPresident and CEO | SSale | −10.4K | $61.12 | −$636.6K | −0.9%1.21M after | |
| Feb 23, 2023 (view filing) | Feb 22 | 1 day | Conroy Kevin TPresident and CEO | SSale | −4.76K | $62.72 | −$298.8K | −0.4%1.20M after | |
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Conroy Kevin TPresident and CEO | SSale | −14.6K | $65.59 | −$958.7K | −1.2%1.19M after |